As of 2024-12-15, the EV/EBITDA ratio of 4D Pharma PLC (DDDD.L) is -2.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DDDD.L's latest enterprise value is 24.19 mil GBP. DDDD.L's TTM EBITDA according to its financial statements is -11.85 mil GBP. Dividing these 2 quantities gives us the above DDDD.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.4x - 6.4x | 5.8x |
| Forward P/E multiples | 7.1x - 12.0x | 8.7x |
| Fair Price | (43.87) - (39.09) | (45.16) |
| Upside | -363.3% - -334.6% | -371.1% |
| Date | EV/EBITDA |